Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder treatment. Immunotherapy and chemotherapy.

A Lopez-Beltran1

  • 1Department of Pathology, Cordoba University Medical School, Spain. em1lobea@lucano.uco.es

The Urologic Clinics of North America
|September 24, 1999
PubMed
Summary

Treatments for bladder cancer cause cellular changes, often mistaken for cancer. These therapy-associated abnormalities in urothelial cells are common in cytology but not diagnostic of treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathology without microscope: From a projection screen to a virtual slide.

Pathology, research and practice·2020
Same author

Epigenetic modulations and lineage plasticity in advanced prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Virchows Archiv : an international journal of pathology·2020
Same author

Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2019
Same author

Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises.

Journal of biological regulators and homeostatic agents·2015
Same author

Pathology of upper tract urothelial carcinoma with emphasis on staging.

International journal of immunopathology and pharmacology·2015

Area of Science:

  • Uropathology
  • Oncology
  • Cytopathology

Background:

  • Bladder cancer treatments encompass surgery, chemotherapy, radiotherapy, and immunotherapy.
  • Existing literature on bladder cancer therapy lacks detail on tissue and cellular changes post-treatment.
  • Urinary cytology and biopsy can reveal urothelial cell alterations due to therapy.

Purpose of the Study:

  • To review the tissue and cellular manifestations of the urinary bladder following various cancer treatments.
  • To highlight the diagnostic challenges posed by therapy-associated cytologic abnormalities.

Main Methods:

  • Literature review of studies on bladder cancer treatments and their cytologic/histologic effects.
  • Analysis of common pathological changes observed in urothelial cells post-therapy.

Main Results:

  • Therapy-associated cytologic abnormalities are frequent findings in urothelial cytology.
  • These abnormalities are the primary cause of false-positive results in urothelial cytology.
  • Pathologic changes include inflammation, vascular abnormalities, and urothelial atypia (degenerative/regenerative).

Conclusions:

  • Observed urothelial cell changes are indicative of treatment effects, not specific outcomes.
  • Understanding these changes is crucial for accurate interpretation of urinary cytology and biopsies in treated patients.

Related Experiment Videos